Kristian Reckzeh

7PUBLICATIONS
39CO-AUTHORS
Molecular targetsHaematological tumoursTissue engineeringEpigenetics (incl. genome methylation and epigenomics)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Jan 09, 2026
Sym024 Interacts with a Unique Epitope on the CD73 Homodimer, Favoring Effective Bivalent Binding to Improve Anti-PD-1 Therapy.

Janus S Jakobsen, Michael M Grandal, Randi W Hansen

|Jun 23, 2022
Transcription factor-driven coordination of cell cycle exit and lineage-specification in vivo during granulocytic differentiation : In memoriam Professor Niels Borregaard.

Kim Theilgaard-Mönch, Sachin Pundhir, Kristian Reckzeh

|Mar 21, 2022
Phosphorylation of SHP2 at Tyr62 Enables Acquired Resistance to SHP2 Allosteric Inhibitors in FLT3-ITD-Driven AML.

Anamarija Pfeiffer, Giulia Franciosa, Marie Locard-Paulet

|Mar 05, 2022
Inhibition of Oxidized Nucleotide Sanitation By TH1579 and Conventional Chemotherapy Cooperatively Enhance Oxidative DNA Damage and Survival in AML.

Anders Centio, Montserrat Estruch, Kristian Reckzeh

|Feb 07, 2022
TET2 deficiency cooperates with CBFB-MYH11 to induce acute myeloid leukaemia and represents an early leukaemogenic event.

Kristian Reckzeh, Montserrat Estruch, Mina Ali

|Dec 10, 2020
Targeted inhibition of cooperative mutation- and therapy-induced AKT activation in AML effectively enhances response to chemotherapy.

Montserrat Estruch, Kristian Reckzeh, Camilla Vittori

Pageof 2

Frequent Collaborators

5 joint publications

Kim Theilgaard-Mönch

3 joint publications

Montserrat Estruch Alrich

2 joint publications

Bo T Porse

2 joint publications

Sophia Engelhard